KRAS mutation of extraovarian implants of serous borderline tumor: prognostic indicator for adverse clinical outcome.

MLA

Zuo, Tao, et al. “KRAS Mutation of Extraovarian Implants of Serous Borderline Tumor: Prognostic Indicator for Adverse Clinical Outcome.” Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, vol. 31, no. 2, Feb. 2018, pp. 350–57. EBSCOhost, https://doi.org/10.1038/modpathol.2017.121.

APA

Zuo, T., Wong, S., Buza, N., & Hui, P. (2018). KRAS mutation of extraovarian implants of serous borderline tumor: prognostic indicator for adverse clinical outcome. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, 31(2), 350–357. https://doi.org/10.1038/modpathol.2017.121

Chicago

Zuo, Tao, Serena Wong, Natalia Buza, and Pei Hui. 2018. “KRAS Mutation of Extraovarian Implants of Serous Borderline Tumor: Prognostic Indicator for Adverse Clinical Outcome.” Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc 31 (2): 350–57. doi:10.1038/modpathol.2017.121.